Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients

NeuroMolecular Medicine

Volumn 5, Issue 3, 2004, Pages 243-251

  Liou, Ying Jay ^a,b   Liao, Ding Lieh ^c   Chen, Jen Yeu ^a   Wang, Ying Chieh ^a,d   Lin, Chao Cheng ^a   Bai, Ya Mei ^a,b   Yu, Shun Chieh ^e   Lin, Ming Wei ^b,f   Lai, I Ching ^d,f  

^a YULI VETERANS HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Pali Psychiatric Hospital   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e Yuli Hospital Department of Health Taiwan   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Association study; BDNF; DRD3; Polymorphism; Tardive dyskinesia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORPROMAZINE; DOPAMINE 3 RECEPTOR; GLYCINE; METHIONINE; NEUROLEPTIC AGENT; NEUROTROPHIN; SERINE; VALINE;

ADULT; ALLELE; ARTICLE; CHINESE; CORRELATION ANALYSIS; DOPAMINE RELEASE; DRD3 GENE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INVOLUNTARY MOVEMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; RECEPTOR GENE; SAMPLING; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TARDIVE DYSKINESIA;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DNA MUTATIONAL ANALYSIS; DYSKINESIA, DRUG-INDUCED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SCHIZOPHRENIA; TAIWAN;

RODENTIA;

EID: 12344281670     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:5:3:243     Document Type: Article

References (40)

1. Accili D., Fishburn C. S., Drago J., et al. (1996) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93, 1945-1949. etc.
2. Altar C. A., Boylan C. B., Jackson C., et al. (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA 89, 11,347-11,351.
3. Beck K. D., Knusel B., and Hefti F. (1993) The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52, 855-866.
4. Bergen J., Kitchin R., and Berry G. (1992) Predictors of the course of tardive dyskinesia in patients receiving neuroleptics. Biol. Psychiatry 32, 580-594.
5. Casey D. E. (1999) Tardive dyskinesia and atypical antipsychotic drugs. Schizophr. Res. 35 (Suppl.), S61-S66.
6. Casey D. E. (2000) Tardive dyskinesia: pathophysiology and animal models. J. Clin. Psychiatr. 61 (Suppl. 4), 5-9.
7. Chong S. A., Tan E. C., Tan C. H., Mythily, and Chan Y. H. (2003) Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia. Am. J. Med. Genet. 116B, 51-54.
8. Crocq M. A., Mant R., Asherson P., et al. (1992) Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J. Med. Genet. 29, 858-860.
9. Dawson N. M., Hamid E. H., Egan M. F., and Meredith G. E. (2001) Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment. Synapse 39, 70-81.
10. Dluzen D. E., Gao X., Story G. M., Anderson L. I., Kucera J., and Walro J. M. (2001) Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp. Neurol. 170, 121-128.
11. Dluzen D. E., Story G. M., Xu K., Kucera J., and Walro J. M. (1999) Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp. Neurol. 160, 500-507.
12. Egan M. F., Kojima M., Callicott J. H., et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
13. Garcia-Barcelo M. M., Lam L. C., Ungvari G. S., Lam V. K., and Tang W. K. (2001) Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. J. Neural. Transm. 108, 671-677.
14. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J. C., and Sokoloff P. (2001) BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411, 86-89.
15. Hong C. J., Yu Y. W., Lin C. H., and Tsai S. J. (2003) An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 349, 206-208.
16. Klawans H. L., Jr. (1973) The pharmacology of tardive dyskinesias. Am. J. Psychiatr. 130, 82-86.
17. Knusel B., Winslow J. W., Rosenthal A., et al. (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA 88, 961-965.
18. Lahiri D. K. and Nurnberger J. I., Jr. (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19, 5444.
19. Lerer B., Segman R. H., Fangerau H., et al. (2002) Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 27, 105-119.
20. Liao D. L., Yeh Y. C., Chen H. M., Chen H., Hong C. J., and Tsai S. J. (2001) Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Neuropsychobiology 44, 95-98.
21. Liou Y. J., Wang Y. C., Bai Y. M., et al. (2004) Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patients. Neuropsychobiology 49, 167-173.
22. Lovlie R., Daly A. K., Blennerhassett R., Ferrier N., and Steen V. M. (2000) Homozygosity for the Gly-9 variant of the dopamine D3 receptor and risk for tardive dyskinesia in schizophrenic patients. Int. J. Neuropsychopharmacol. 3, 61-65.
23. Maisonpierre P. C., Le Beau M. M., Espinosa R., III, et al. (1991) Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10, 558-568.
24. Martin-Iverson M. T., Todd K. G., and Altar C. A. (1994) Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J. Neurosci. 14, 1262-1270.
25. Momose Y., Murata M., Kobayashi K., et al. (2002) Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann. Neurol. 51, 133-136.
26. Munetz M. R. and Benjamin S. (1988) How to examine patients using the Abnormal Involuntary Movement Scale. Hosp. Community Psychiatr. 39, 1172-1177.
27. Nanko S., Kunugi H., Hirasawa H., Kato N., Nabika T., and Kobayashi S. (2003) Brain-derived neurotrophic factor gene and schizophrenia: poly-morphism screening and association analysis. Schizophr. Res. 62, 281-283.
28. Ohmori O., Shinkai T., Hori H., Matsumoto C., and Nakamura J. (2003) A perspective on molecular genetic studies of tardive dyskinesia: one clue for individualized antipsychotic drug therapy. Progr. Neuro. Psychopharmacol. Biol. Psychiatr. 27, 581-586.
29. Rietschel M., Krauss H., Muller D. J., et al. (2000) Dopamine D3 receptor variant and tardive dyskinesia. Eur. Arch. Psychiatr. Clin. Neurosci. 250, 31-35.
30. Schooler N. R. and Kane J. M. (1982) Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatr. 39, 486-487.
31. Segman R., Neeman T., Heresco-Levy U., et al. (1999) Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol. Psychiatr. 4, 247-253.
32. Segman R. H., Heresco-Levy U., Finkel B., et al. (2000) Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility. Psychopharmacology (Berl) 152, 408-413.
33. Shen R. Y., Altar C. A., and Chiodo L. A. (1994) Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc. Natl. Acad. Sci. USA 91, 8920-8924.
34. Steen V. M., Lovlie R., MacEwan T., and McCreadie R. G. (1997) Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol. Psychiatr. 2, 139-145.
35. Suzuki M., Hurd Y. L., Sokoloff P., Schwartz J. C., and Sedvall G. (1998) D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 779, 58-74.
36. Szekeres G., Juhasz A., Rimanoczy A., Keri S., and Janka Z. (2003) The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia. Schizophr. Res. 65, 15-18.
37. Tsai S. J., Hong C. J., Liu H. C., Liu T. Y., Hsu L. E., and Lin C. H. (2004) Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology 49, 10-12.
38. Wang Y. C., Liou Y. J., Liao D. L., et al. (2004) Association analysis of a neural nitric oxide synthase gene polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients. J. Neural Transm. 111, 623-629.
39. Woo S. I., Kim J. W., Rha E., et al. (2002) Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics. Psychiatr. Clin. Neurosci. 56, 469-474.
40. Zhang Z. J., Zhang X. B., Hou G., Yao H., and Reynolds G. P. (2003) Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia. Psychiatr. Genet. 13, 187-192.